Jim Simons
FLXN

Jim Simons’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Jim Simons’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-12,700
Closed -$100K – 3886
2020
Q1 		$100K Sell
12,700
-13,900
-52% -$209K ﹤0.01% 3229
2019
Q4 		$551K Sell
26,600
-15,800
-37% -$266K ﹤0.01% 2869
2019
Q3 		$581K Buy
+42,400
New +$503K ﹤0.01% 2814
2016
Q2 		– Sell
-124,500
Closed -$1.15M – 3577
2016
Q1 		$1.15M Buy
+124,500
New +$1.51M ﹤0.01% 2517
2015
Q3 		– Sell
-15,100
Closed -$331K – 3449
2015
Q2 		$331K Sell
15,100
-11,006
-42% -$222K ﹤0.01% 2846
2015
Q1 		$588K Buy
+26,106
New +$605K ﹤0.01% 2535

Other funds holding FLXN

MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Jim Simons's FLXN Position: Q2 2020 in Review

Jim Simons sold out of Flexion Therapeutics, Inc. (FLXN) in Q2 2020, closing a stake of 12,700 shares — an estimated $100K sold.

Jim Simons first reported a position in FLXN in Q1 2015 and held it in 6 quarters. The position peaked at $1.15M in Q1 2016. 125 funds tracked by Wall St. Rank hold FLXN as of Q2 2020.

  • Jim Simons reported no remaining Flexion Therapeutics, Inc. position as of Q2 2020 after selling out during the quarter.
  • Jim Simons sold 12,700 Flexion Therapeutics, Inc. shares in Q2 2020, an estimated $100K.
  • Jim Simons first reported a position in Flexion Therapeutics, Inc. in Q1 2015 and held it in 6 quarters.
  • Jim Simons's Flexion Therapeutics, Inc. position peaked at $1.15M in Q1 2016.
  • 125 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q2 2020.

Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.